Cytosorbents Corporation CTSO
$5.75
$0.020.35%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.41M | 4.81M | 6.25M | 7.54M | 10.20M |
| Total Receivables | 6.79M | 7.15M | 7.55M | 7.43M | 7.74M |
| Inventory | 3.69M | 4.48M | 5.28M | 4.00M | 3.71M |
| Prepaid Expenses | 852.00K | 1.31M | 1.55M | 2.35M | 1.33M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 15.74M | 17.76M | 20.63M | 21.31M | 22.99M |
|
|
|||||
| Total Current Assets | 15.74M | 17.76M | 20.63M | 21.31M | 22.99M |
| Net Property, Plant & Equipment | 17.78M | 18.28M | 18.75M | 19.27M | 19.69M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.86M | 2.95M | 3.23M | 3.59M | 3.74M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.58M | 1.57M | 1.58M | 1.58M | 1.58M |
| Total Assets | 37.96M | 40.56M | 44.18M | 45.75M | 47.99M |
|
|
|||||
| Total Accounts Payable | 2.00M | 3.13M | 2.87M | 3.04M | 3.39M |
| Total Accrued Expenses | 5.06M | 4.72M | 5.06M | 6.15M | 4.61M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.74M | 7.21M | 541.00K | 518.00K | 495.00K |
| Total Finance Division Other Current Liabilities | 2.22M | 1.24M | 1.24M | 409.00K | 1.35M |
| Total Other Current Liabilities | 2.22M | 1.24M | 1.24M | 409.00K | 1.35M |
| Total Current Liabilities | 24.02M | 16.30M | 9.71M | 10.11M | 9.84M |
|
|
|||||
| Total Current Liabilities | 24.02M | 16.30M | 9.71M | 10.11M | 9.84M |
| Long-Term Debt | 3.09M | 10.31M | 16.67M | 14.57M | 14.38M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 11.60M | 11.75M | 11.90M | 12.05M | 12.19M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 38.71M | 38.37M | 38.28M | 36.73M | 36.40M |
|
|
|||||
| Common Stock & APIC | 322.00M | 321.63M | 321.09M | 319.57M | 319.09M |
| Retained Earnings | -321.75M | -317.34M | -312.21M | -306.71M | -303.54M |
| Treasury Stock & Other | -996.00K | -2.10M | -2.98M | -3.84M | -3.96M |
| Total Common Equity | -751.00K | 2.19M | 5.90M | 9.02M | 11.59M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -751.00K | 2.19M | 5.90M | 9.02M | 11.59M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -751.00K | 2.19M | 5.90M | 9.02M | 11.59M |
|
|
|||||